Start my visit

Weight care · Daily pill

Foundayo (orforglipron)

Foundayo is Lilly’s once-daily GLP-1 pill for chronic weight management. You pay LillyDirect’s published price for the medicine, plus $79/mo for Level care, including a muscle-protection plan.

$79/mo care + medication from $149/mo care + manufacturer price

Care is $79/mo. Medication is paid to LillyDirect: $149 (0.8 and 2.5 mg), $199 (5.5 mg, promotional price through December 31, 2026), $299 (9, 14.5 and 17.2 mg). Prices checked November 2026 and can change. We don’t mark up the drug. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Start my visit
Preparing to serve you soonCheckout opens at launch. Start your visit to save your spot.

Foundayo (orforglipron) · $79/mo care + medication from $149/mo

Texas-licensed doctorsLicensed U.S. pharmacyDiscreet delivery
Foundayo (orforglipron), Level Health Rx

What it is

Foundayo™ (orforglipron), an FDA-approved once-daily oral GLP-1 medicine for chronic weight management. Foundayo is Lilly’s once-daily GLP-1 pill for chronic weight management. You pay LillyDirect’s published price for the medicine, plus $79/mo for Level care, including a muscle-protection plan.

What it does and how it works

Orforglipron is a small-molecule GLP-1 receptor agonist taken by mouth. It acts on appetite and blood-sugar pathways, similar in class to injectable GLP-1 medicines, but it is its own approved product with its own dosing. Unlike the Wegovy pill, it can be taken any time of day, with or without food. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Who it’s for

Adults in Texas who meet the FDA label’s BMI and health criteria and whose history is safe for a GLP-1, after a visit with a Texas-licensed doctor. It is not for people with a personal or family history of medullary thyroid carcinoma or MEN 2, and it is not for pregnancy.

Potential benefits

These are possible effects reported in research or by patients — not a guarantee, and not a claim that this product cures or treats a disease unless it’s FDA-approved for that use.

How you take it

One tablet a day, any time of day, with or without food. No meal or water-volume limits like the Wegovy pill. Your doctor sets the dose and how it is increased. Your doctor decides the exact dose and schedule.

Why people choose it

  • A daily pill, no needles
  • Can be taken with or without food
  • FDA-approved; bought at LillyDirect’s published self-pay price

Good to know

  • Can cause nausea, vomiting, diarrhea or constipation, especially as the dose increases
  • Not for people with a personal or family history of MTC or MEN 2
  • Weight often returns if the medicine is stopped; it is not muscle-sparing on its own
Details: side effects, who shouldn’t use it, and regulatory status

Common side effects

The most common effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach pain, often during dose increases. Serious risks described on the label include possible thyroid tumors (the reason for the MTC/MEN 2 warning), pancreatitis, gallbladder problems, and hypoglycemia when used with insulin or a sulfonylurea. Stop and get care for severe abdominal pain, signs of an allergic reaction, or suicidal thoughts.

Who shouldn’t use it

Do not use if you or a family member have had MTC or MEN 2, or if you are pregnant or planning pregnancy soon. Tell your doctor about pancreatitis, gallbladder disease, type 1 diabetes, kidney problems, and all diabetes medicines. We do not prescribe compounded GLP-1s.

Regulatory status

This medicine is FDA-approved for the uses described on this page. Your doctor will confirm whether that approved use fits you.

What you pay

Everything, upfront.

What’s included

$79/mo care (visits, muscle-protection plan, messaging) plus Foundayo at LillyDirect’s published self-pay price. We don’t mark up the medicine.

  • Unlimited messaging with your care team. Message anytime; a health coach replies the same business day. Medical questions go to your doctor. Not for emergencies — call 911. Message the care team.
  • Cancel or pause online, in one click, before the next renewal. Terms · Request cancel or pause.
  • Level is cash-pay and does not bill or accept traditional health insurance. Pay with an HSA or FSA card. We’ll email an itemized receipt. Reimbursement depends on your plan — we don’t promise it.
Foundayo (orforglipron)Care is $79/mo. Medication is paid to LillyDirect: $149 (0.8 and 2.5 mg), $199 (5.5 mg, promotional price through December 31, 2026), $299 (9, 14.5 and 17.2 mg). Prices checked November 2026 and can change. We don’t mark up the drug. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.$79/mo care + medication from $149/mo

GLP-1 medicines for weight are FDA-approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Your doctor will confirm what fits you. Every GLP-1 plan includes a muscle-protection plan (protein target, resistance-training guidance, follow-up; optional DEXA referral). Retatrutide is not FDA-approved; you can join a notify list. We don’t offer compounded semaglutide or tirzepatide.

Product images show Level Health Rx branding for illustration. Your medication is dispensed in the pharmacy’s or manufacturer’s packaging.

Other options

Weekly GLP-1 injection, Level Health Rx
Weekly injection

Weekly GLP-1 injection

Weekly FDA-approved GLP-1 injections — Wegovy® (semaglutide) or Zepbound® (tirzepatide) — help many adults with obesity or overweight eat less and lose weight, alongside diet and activity.

How it’s taken: One small injection a week under the skin, with the dose raised slowly over the first months.

  • Just once a week
  • The most studied GLP-1 weight medicines
  • Zepbound vials offer the lowest Zepbound price
  • Needles (pens are simple; vials need syringes)
  • Nausea, diarrhea or constipation are common early on
  • Price goes up at higher doses
From $199/mo medication

Wegovy pen: $199/mo for the first 2 fills (new patients, through Dec 31, 2026), then $349/mo; Wegovy HD 7.2 mg $399/mo (NovoCare). Zepbound: $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) if refilled within 45 days (LillyDirect). Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Details

GLP-1 medicines mimic a gut hormone that helps regulate appetite and blood sugar. Tirzepatide also acts on GIP. You inject once a week, and the dose is increased slowly to limit stomach side effects. You buy the medicine at the manufacturer’s self-pay price; Level care is $79/mo (example). Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Who it’s for. Adults with a BMI of 30 or more, or 27 or more plus a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol, after a Texas-licensed doctor reviews your history. We do not prescribe compounded semaglutide or tirzepatide.

Open the full Weekly GLP-1 injection page for side effects, what’s included, and sources.

Daily GLP-1 pill, Level Health Rx
Daily pill

Daily GLP-1 pill

If you’d rather skip a weekly shot, two FDA-approved daily pills are now available for weight: the Wegovy® pill (oral semaglutide) and Foundayo™ (orforglipron).

How it’s taken: One pill a day. Wegovy pill: on an empty stomach with a sip of water, then wait 30 minutes before eating. Foundayo: any time of day, no food or water rules.

  • No needles
  • Lowest starting price
  • Easy to travel with
  • Must be taken every day
  • Wegovy pill has strict morning timing rules
  • Same stomach side effects as the shots
From $149/mo medication

Wegovy pill: $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) per month (NovoCare). Foundayo: $149 (0.8 mg and, through Dec 31, 2026, 2.5 mg), $199 (5.5 mg, promo), $299 (9 mg), $299–$349 (14.5/17.2 mg) (LillyDirect). Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Details

The Wegovy pill is semaglutide taken on an empty stomach with a sip of water, then waiting before food. Foundayo is a non-peptide GLP-1 pill that can be taken with or without food. Both reduce appetite through GLP-1 pathways. Your doctor helps you choose. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Who it’s for. Same BMI rules as the weekly shots: 30 or more, or 27 or more with a weight-related condition. A Texas-licensed doctor confirms what fits. We do not prescribe Rybelsus® or the Ozempic® pill for weight — those are approved for type 2 diabetes.

Open the full Daily GLP-1 pill page for side effects, what’s included, and sources.

Wegovy pill (oral semaglutide), Level Health Rx
Daily pill

Wegovy pill (oral semaglutide)

The Wegovy pill is oral semaglutide, FDA-approved in December 2025 for chronic weight management. Care is $79/mo; the medicine is billed at NovoCare’s published self-pay price.

How it’s taken: Taken in the morning on an empty stomach with a sip of water. Wait 30 minutes before food, drink or other oral medicines. Your doctor sets the dose.

  • A daily pill, no needles
  • The same active ingredient as Wegovy injection, in tablet form
  • Brand label also includes a cardiovascular-risk indication
  • FDA-approved; bought at NovoCare’s published self-pay price
  • Must be taken on an empty stomach, then wait 30 minutes
  • Can cause nausea, vomiting, diarrhea or constipation
  • Not for people with a personal or family history of MTC or MEN 2
  • Weight often returns if the medicine is stopped
$79/mo care + medication from $149/mo care + manufacturer price

Care is $79/mo. Medication is paid to NovoCare: $149 (1.5 mg), $199 (4 mg), $299 (9 or 25 mg). Prices checked November 2026 and can change. We don’t mark up the drug. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Details

Semaglutide is a GLP-1 receptor agonist. The tablet is taken once daily on an empty stomach with a sip of water; you then wait 30 minutes before food, drink or other oral medicines so the dose can absorb. The brand label also includes a cardiovascular-risk indication. Every GLP-1 plan includes a muscle-protection plan: a protein target, guidance to do resistance training about 2–3 days a week, and follow-up from your care team. In a 40-week randomized trial published in Nature Medicine on November 9, 2026, adding three weekly resistance-training sessions to tirzepatide reduced lean soft-tissue loss from 4.67 kg to 3.57 kg and increased strength, while fat loss was similar (Green et al.). We can refer you for a DEXA scan; you pay the imaging center. This is supportive care, not a guarantee.

Who it’s for. Adults in Texas who meet the FDA label’s criteria and can follow the empty-stomach instructions, after a visit with a Texas-licensed doctor. Not for people with a personal or family history of MTC or MEN 2, and not for pregnancy.

Open the full Wegovy pill (oral semaglutide) page for side effects, what’s included, and sources.

Common questions

What is Foundayo?

Foundayo (orforglipron) is an FDA-approved daily pill for chronic weight management. It was approved on April 1, 2026. It is not a compounded drug.

How much does Foundayo cost at Level?

$79/mo for care, plus the medicine at LillyDirect’s published self-pay price: $149, $199 or $299 a month depending on dose (checked November 2026). We don’t mark it up.

Does Foundayo preserve muscle?

No drug we can sell today is approved as muscle-sparing. In ATTAIN-1, about 27% of weight lost on orforglipron was lean mass. We include a muscle-protection plan (protein and resistance training) because a November 2026 trial found that lifting during tirzepatide reduced lean-mass loss and improved strength.

Foundayo or the Wegovy pill?

Both are daily FDA-approved pills with different instructions and prices. Foundayo has no meal-timing rules; the Wegovy pill is taken on an empty stomach with a 30-minute wait. Your doctor helps you choose.

Not sure which one? Your doctor will help.

Tell us your preference in the visit. You can always switch.

Start my visit

Sources

  1. LillyDirect: Foundayo self-pay prices
  2. Green DJ, Haynes A, Underwood DR, et al. Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial. Nat Med. Published 9 Nov 2026.
  3. FDA: Concerns with unapproved GLP-1 drugs used for weight loss
  4. FDA: FDA approves new medication for chronic weight management (Zepbound, 2023)
  5. Wegovy Medication Guide (Novo Nordisk)

Prices checked Nov 2026. This page is general information, not medical advice.

Last updated .